• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Cyclin-L1 (CCNL1)

ACP09841

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP09841 Target NameCCNL1
Target SynonymsCCNL1; BM-001; UNQ530/PRO1073; Cyclin-L1; Cyclin-LFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-526
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9UK58
Background Information
  • Uniprot Id

    Q9UK58

  • Target Species

    Human

  • Target Name

    CCNL1

  • Target Full Name

    Cyclin-L1

  • Target Function

    Involved in pre-mRNA splicing. Functions in association with cyclin-dependent kinases (CDKs). Inhibited by the CDK-specific inhibitor CDKN1A/p21. May play a role in the regulation of RNA polymerase II (pol II). May be a candidate proto-oncogene in head and neck squamous cell carcinomas (HNSCC).

  • Target Subcellular Location

    Nucleus speckle. Nucleus, nucleoplasm.

  • Target Protein Families

    Cyclin family, Cyclin L subfamily

  • Target Tissue Specificity

    Widely expressed. Overexpression in primary tumors of head and neck squamous cell carcinomas (HNSCC).

  • Target Synonyms

    CCNL1; BM-001; UNQ530/PRO1073; Cyclin-L1; Cyclin-L

Inquire Recombinant Human Cyclin-L1 (CCNL1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification